News | Artificial Intelligence | January 25, 2019

Chatbot application guided by artificial intelligence can answer patient questions 24/7 with clinically validated information

Wefight Unveils Vik Breast Chatbot at CES 2019

January 25, 2019 — French startup company Wefight unveiled the English version of its Vik Breast chatbot for breast cancer patients at the 2019 Consumer Electronics Show (CES), Jan. 8-11 in Las Vegas. Vik Breast is a virtual companion that uses artificial intelligence (AI) to respond to almost any patient question 24 hours a day, 7 days a week.

Doctors are not available 24/7 to answer all the concerns a patient may have during treatment, which can make patients anxious and frustrated. All the functionalities of the Vik application, launched in 2017 in France, are adapted to breast cancer, in order to respond as precisely as possible to any questions the patients may have.                     

Vik Breast is freely available online for iOS and Android platforms, and via Facebook Messenger. The chatbot uses AI that allows it to respond efficiently at any time.

Vik Breast provides advice on:

  • Treatment: how medication be taken, how to deal with the side effects;
  • Life Quality: nutrition, sport, social life;
  • Sexuality: the impact of medication, psychology;
  • Administrative information: refund, transport; and
  • General Content: for detection, prevention methods, diagnosis techniques, chemotherapies or radiotherapies.    

Furthermore, Vik helps the patient through appointments reminders, pill reminders, a side effects notebook, clinical trials recruitments, and the “question of the day” to share their experience and learn from others.

All the answers provided by Vik are written and checked by doctors or pharmacists. Moreover, all information is regularly updated in order to conform to national regulations and scientific publications.

For more information: www.wefight.co


Related Content

News | Advanced Visualization

July 28, 2025 — Frost & Sullivan has named Siemens Healthineers the 2025 North America Company of the Year in the ...

Time July 28, 2025
arrow
News | Radiology Imaging

July 25, 2025 — Data in recent staffing surveys from the American Society of Radiologic Technologists show that vacancy ...

Time July 25, 2025
arrow
News | Prostate Cancer

July 9, 2025 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time July 09, 2025
arrow
News | Breast Imaging

July 8, 2025 — QT Imaging Holdings, has appointed Elaine Iuanow, MD, as chief medical officer (CMO) and Kim Du as senior ...

Time July 09, 2025
arrow
News | Breast Imaging

July 7, 2025 — SimonMed Imaging, one of the largest outpatient medical imaging providers in the United States, has ...

Time July 08, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

July 2, 2025 — Philips has received FDA 510(k) clearance for SmartSpeed Precise1 MR’s latest deep learning ...

Time July 03, 2025
arrow
News | Ultrasound Imaging

July 1, 2025 — UPDATE: The final paper is now available at: JMIR AI - ChatGPT-4–Driven Liver Ultrasound Radiomics ...

Time July 01, 2025
arrow
News | Magnetic Resonance Imaging (MRI)

June 26, 2025 — Siemens Healthineers has received Food and Drug Administration clearance for the Magnetom Flow.Ace, its ...

Time June 26, 2025
arrow
News | Prostate Cancer

June 26, 2025 – Quibim, a global provider of quantitative medical imaging solutions, has launched AI-QUAL, a new feature ...

Time June 26, 2025
arrow
News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
Subscribe Now